ARMC
MRNA icon

American Research & Management Company’s Moderna MRNA Stock Holding History

American Research & Management Company’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$12K Hold
104
– – ﹤0.01% 282
2022
Q2 		$15K Hold
104
– – ﹤0.01% 277
2022
Q1 		$18K Hold
104
– – ﹤0.01% 277
2021
Q4 		$26K Hold
104
– – 0.01% 248
2021
Q3 		$40K Hold
104
– – 0.01% 219
2021
Q2 		$24K Sell
104
-5
-5% -$894 0.01% 260
2021
Q1 		$14K Sell
109
-5
-4% -$725 ﹤0.01% 276
2020
Q4 		$12K Buy
114
+94
+470% +$9.51K ﹤0.01% 286
2020
Q3 		$1K Buy
+20
New +$1.39K ﹤0.01% 340

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

American Research & Management Company's MRNA Position: Q3 2022 in Review

American Research & Management Company held its Moderna (MRNA) position steady in Q3 2022 at 104 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #282.

American Research & Management Company first reported a position in MRNA in Q3 2020 and has held it in 9 quarters since. The position peaked at $40K in Q3 2021. 916 funds tracked by Wall St. Rank hold MRNA as of Q3 2022.

  • American Research & Management Company held 104 shares of Moderna worth $12K as of Q3 2022.
  • American Research & Management Company left its Moderna share count unchanged in Q3 2022.
  • Moderna made up ﹤0.01% of American Research & Management Company's portfolio in Q3 2022, its #282 holding.
  • American Research & Management Company first reported a position in Moderna in Q3 2020 and has held it in 9 quarters since.
  • American Research & Management Company's Moderna position peaked at $40K in Q3 2021.
  • 916 funds tracked by Wall St. Rank held Moderna as of Q3 2022.

Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.